AstraZeneca PLC/ GB0009895292 /
| 2024-07-22 5:35:30 PM | Chg. +137.00 | Volume | Bid5:35:30 PM | Ask5:35:30 PM | Market Capitalization | Dividend Y. | P/E Ratio |
|---|---|---|---|---|---|---|---|
| 12,260.00GBX | +1.13% | 97,206 Turnover(GBP): 11.94 mill. |
-Bid Size: - | -Ask Size: - | 190.12 bill.GBP | - | - |
Fundamentals
| FY 2023 | Growth (1Y) | |
|---|---|---|
| Per Share | ||
| Earnings per Share: | 3.84 USD | 81.13% |
| EPS Diluted: | - USD | 80.57% |
| Revenues per Share: | 29.55 USD | 3.28% |
| Book Value per Share: | 25.25 USD | 5.68% |
| Cash Flow per Share: | 6.67 USD | 5.46% |
| Dividend per Share: | 2.90 USD | 0.00% |
| Total | in mill. | |
| Revenues: | 45,811.00 USD | 3.29% |
| Net Income: | 5,955.00 USD | 84.48% |
| Operating Cash Flow: | 10,345.00 USD | - |
| Cash and Cash Equivalents: | 5,840.00 USD | - |
Valuation Ratios
| Current | Latest FY* | |
|---|---|---|
| P/E Ratio: | 41.24 | 35.16 |
| P/S Ratio: | 5.36 | 4.57 |
| P/BV ratio: | 6.27 | 5.35 |
| P/CF Ratio: | 23.73 | 20.23 |
| PEG: | 0.51 | 0.43 |
| Earnings Yield: | 2.42% | 2.84% |
| Dividend Yield: | 1.83% | 2.15% |
| Market Capitalization | ||
| Market Capitalization: | 190.12 bill. GBP | 164.16 bill. GBP |
| Free Float Market Cap.: | - GBP | - GBP |
| Market Cap. / Employee: | 2.11 mill. GBP | 1.83 mill. GBP |
| Shares Outstanding: | 1.55 bill. | |
Profitability
| Gross Profit Margin: | 81.95% |
| EBIT Margin: | 17.88% |
| Net Profit Margin: | 13.00% |
| Return on Equity: | 15.21% |
| Return on Assets: | 5.89% |
Financial Strength
| Liquidity I / Cash Ratio: | 19.12% |
| Liquidity II / Quick Ratio: | 58.82% |
| Liquidity III / Current Ratio: | 82.03% |
| Debt / Equity Ratio: | 158.33% |
| Dynam. Debt / Equity Ratio: | 599.09% |
Efficiency
| Employees: | 89,900 |
| Personal Expenses / Employee: | - USD |
| Revenues / Employee: | 509,577.31 USD |
| Net Income / Employee: | 66,240.27 USD |
| Total Assets / Employee: | 1,124,794.22 USD |
| * Fiscal Year End: | 2023-12-31 |
| Accounting Standard: | IFRS |
| Currency: | USD |
